Zafar A,Sher F .2018 .Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J, 26 : 453-61.
Hussain R,Hassali MA .2019 .Current status and future prospects of pharmacovigilance in Pakistan. J Pharm Policy Pract, 12 : 1-3.
Atif M,Ahmad M,Saleem Q,Curley L .2017 .Pharmaceutical policy in countries with developing healthcare systems. Cham Adis, : 25-44.
Newton PN,Bond KC,Babar Z. COVID KC .2020 .-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health, 8 : e754-e755.
Wilbur K. .2013 .Pharmacovigilance in the Middle East. Drug Safety, 36 : 25-30.
. .. , : .
Montastruc J,Lafaurie M,Canecaude C. .2021 .Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. Brit J Clin Pharma, 87 : 4334-40.
Adhikari A,Indu R,Ray M .2017 .Bhattacharya S. Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: A pharmacovigilance study. Int J Adv Med, 4 : 1685-89.
Hussain R,Hassali MA,Hashmi F,Farooqui M. .2018 .A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan. J Pharm Policy Pract, 11 : 16-20.
Hussain R,Hassali MA,Muneswarao J .2020 .Physicians' understanding and practices of Pharmacovigilance: qualitative experience from a lower middle-income country. Int J Environ Res Public Health, 17 : 2209.
Almandil NB .2016 .Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J, 37 : 1359.
Murshid MA,Mohaidin Z,Nee GY .2016 .Influence of pharmacist's expertise on physicians' prescription decisions. Trop J Pharm Res, 15 : 1549-57.
.2022 .. [(accessed on 13 February, : .
Backstrom M,Mjorndal T,Dahlqvist R .2000 .Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol, 56 : 729-32.
Aziz Z,Siang TC,Badarudin NS .2007 .Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Safety, 16 : 223-8.
Hadi MA,Neoh CF,Zin RM .2017 .Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract, 6 : 91-7.
Mikkola L,Suutala E,Parviainen H .2018 .Social support in the workplace for physicians in specialization training. Med Educ Online, 23 : 1435114.
. .Pakistan National Pharmacovigilance Guidelines. Islamabad: Drug Regulatory Authority of Pakistan; 2019, : 95.
Stoynova V,Getov IN,Naseva EK .2013 .Physicians' knowledge and attitude towards adverse event reporting system and result to intervention-Randomized nested trial among Bulgarian physicians. Med Glas, 10 : 365-72.
Dweik R,Stacey D,Kohen D .2017 .Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol, 83 : 875-83.
Shammari TM,Almoslem MJ TM .2018 .Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-centre cross sectional study. Saudi Pharm J, 26 : 925-31.